You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 13, Issue 12

June-2 2021 - 250 articles

Cover Story: Up to one third of all breast cancers are classified as the aggressive HER2-positive subtype, which is associated with a higher risk of recurrence compared to HER2-negative breast cancers. The HER2 hyperactivity associated with this subtype drives tumor growth by up-regulation of mTOR pathways and metabolic adaptation. Combination therapies that simultaneously target HER2 and mTOR improve clinical outcomes compared with HER2 inhibition alone. Drugs that mimic glucose deprivation in HER2-positive breast cancer patients have not been evaluated; however, preclinical studies have shown that the growth of HER2-positive breast tumors is reduced in response to combining the glycolytic inhibitor 2-DG with mTOR inhibitors. Here, we review the role of mTOR, glycolysis, and signaling mechanisms in HER2-positive breast cancer. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (250)

  • Review
  • Open Access
30 Citations
6,232 Views
23 Pages

Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatobiliary Cancers: State of the Art

  • Carmelo Laface,
  • Mariarita Laforgia,
  • Pasquale Molinari,
  • Ippazio Ugenti,
  • Cosmo Damiano Gadaleta,
  • Camillo Porta and
  • Girolamo Ranieri

21 June 2021

Liver functional failure is one of the leading causes of cancer-related death. Primary liver tumors grow up mainly in the liver, and thus happens for liver metastases deriving from other organs having a lower burden of disease at the primary site. Sy...

  • Review
  • Open Access
30 Citations
4,964 Views
13 Pages

21 June 2021

Cancer metabolism involves different changes at a cellular level, and altered metabolic pathways have been demonstrated to be heavily involved in tumorigenesis and invasiveness. A crucial role for oxidative stress in cancer initiation and progression...

  • Article
  • Open Access
40 Citations
4,916 Views
10 Pages

Renal Safety of [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function

  • Florian Rosar,
  • Niklas Kochems,
  • Mark Bartholomä,
  • Stephan Maus,
  • Tobias Stemler,
  • Johannes Linxweiler,
  • Fadi Khreish and
  • Samer Ezziddin

21 June 2021

Background: Radioligand therapy (RLT) targeting prostate-specific membrane antigen (PSMA) is an effective antitumor-treatment in metastatic castration-resistant prostate carcinoma (mCRPC). Concerns of potential nephrotoxicity are based on renal tubul...

  • Article
  • Open Access
20 Citations
5,120 Views
33 Pages

A Comprehensive Bioinformatics Analysis of Notch Pathways in Bladder Cancer

  • Chuan Zhang,
  • Mandy Berndt-Paetz and
  • Jochen Neuhaus

21 June 2021

Background: A hallmark of Notch signaling is its variable role in tumor biology, ranging from tumor-suppressive to oncogenic effects. Until now, the mechanisms and functions of Notch pathways in bladder cancer (BCa) are still unclear. Methods: We use...

  • Article
  • Open Access
8 Citations
4,420 Views
14 Pages

21 June 2021

Objectives: Patients with epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) ultimately acquire resistance to EGFR tyrosine kinase inhibitors (TKIs) during treatment. In 5–22% of these patients, resistance is mediated b...

  • Article
  • Open Access
1 Citations
3,588 Views
12 Pages

High Serum Elafin Prediction of Poor Prognosis of Locoregional Esophageal Squamous Cell Carcinoma

  • I-Chen Wu,
  • Yao-Kuang Wang,
  • Yi-Hsun Chen,
  • Chun-Chieh Wu,
  • Meng-Chieh Wu,
  • Wei-Chung Chen,
  • Wen-Lun Wang,
  • Hung-Shun Lin,
  • Chou-Cheng Chen and
  • Shah-Hwa Chou
  • + 2 authors

21 June 2021

Esophageal squamous cell carcinoma (ESCC) is a highly aggressive tumor known to have locally advanced and metastatic features which cause a dismal prognosis. We sought to determine whether elafin, a non-invasive and secretory small-molecule marker, c...

  • Article
  • Open Access
14 Citations
4,139 Views
19 Pages

Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors

  • Sebastian Gulde,
  • Tobias Wiedemann,
  • Mathias Schillmaier,
  • Isabel Valença,
  • Amelie Lupp,
  • Katja Steiger,
  • Hsi-Yu Yen,
  • Stephen Bäuerle,
  • Johannes Notni and
  • Raul Luque
  • + 5 authors

21 June 2021

Invasive nonfunctioning pituitary tumors (NFPTs) are non-resectable neoplasms associated with frequent relapse and significant comorbidities. Current treatments, including somatostatin receptor 2 (SSTR2)-directed somatostatin analogs (SSAs), often fa...

  • Article
  • Open Access
31 Citations
5,094 Views
12 Pages

Deep Learning with Quantitative Features of Magnetic Resonance Images to Predict Biochemical Recurrence of Radical Prostatectomy: A Multi-Center Study

  • Ye Yan,
  • Lizhi Shao,
  • Zhenyu Liu,
  • Wei He,
  • Guanyu Yang,
  • Jiangang Liu,
  • Haizhui Xia,
  • Yuting Zhang,
  • Huiying Chen and
  • Cheng Liu
  • + 8 authors

21 June 2021

Biochemical recurrence (BCR) occurs in up to 27% of patients after radical prostatectomy (RP) and often compromises oncologic survival. To determine whether imaging signatures on clinical prostate magnetic resonance imaging (MRI) could noninvasively...

  • Article
  • Open Access
21 Citations
4,549 Views
15 Pages

MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma

  • Lisa Kinget,
  • Eduard Roussel,
  • Annelies Verbiest,
  • Maarten Albersen,
  • Cristina Rodríguez-Antona,
  • Osvaldo Graña-Castro,
  • Lucía Inglada-Pérez,
  • Jessica Zucman-Rossi,
  • Gabrielle Couchy and
  • Sylvie Job
  • + 4 authors

21 June 2021

Metastatic clear-cell renal cell carcinoma (m-ccRCC) is characterized by increased hypoxia-induced factor (HIF)-2α and vascular endothelial growth factor receptor (VEGFR)-dependent angiogenesis through loss of function of the von Hippel–Lindau protei...

  • Review
  • Open Access
24 Citations
6,333 Views
27 Pages

An Updated Understanding of the Role of YAP in Driving Oncogenic Responses

  • Giampaolo Morciano,
  • Bianca Vezzani,
  • Sonia Missiroli,
  • Caterina Boncompagni,
  • Paolo Pinton and
  • Carlotta Giorgi

21 June 2021

Yes-associated protein (YAP) has emerged as a key component in cancer signaling and is considered a potent oncogene. As such, nuclear YAP participates in complex and only partially understood molecular cascades that are responsible for the oncogenic...

of 25

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694